文献速递青光眼白内障与屈光手术

3T联合与不联合超声乳化治疗POAG合并白内障的疗效与安全性

[Efficacy and safety of trabeculotome tunnelling trabeculoplasty with versus without phacoemulsification in patients with primary open-angle glaucoma and cataract].
PubMed 文献 · Zhonghua Yan Ke Za Zhi · 2026-01-01

回顾性队列研究纳入59例71眼POAG合并白内障患者,比较3T联合超声乳化IOL植入与单纯3T的6个月疗效。两组眼压均显著降低且组间无差异,联合组视力显著改善、眼压反跳发生率显著低于单纯3T组,6个月成功率组间无差异。

要点

  • 3T联合超声乳化可显著提高POAG合并白内障患者最佳矫正视力,平均改善0.38 logMAR。
  • 联合组眼压反跳发生率20.0%,显著低于单纯3T组的41.7%。
  • 两组术后眼压均显著降低,但组间差异无统计学意义。

核心结论

  • 3T联合白内障摘除手术是治疗POAG合并白内障安全有效的方法,可显著提高视力、有效降低眼压和减少抗青光眼药物数量,且术后并发症少。

研究设计与样本

  • 回顾性队列研究纳入2023年1月至2024年12月成都市中西医结合医院POAG合并白内障患者59例71眼,观察组35眼接受3T联合超声乳化及IOL植入,对照组36眼接受单纯3T。

主要发现

  • 观察组术前眼压(23.76±5.01)mmHg、术后6个月(15.28±2.80)mmHg,对照组术前(24.56±6.08)mmHg、术后6个月15.00(13.50,18.00)mmHg,两组术后均较术前显著降低(P<0.05),组间差异无统计学意义(P>0.05)。
  • 术后6个月观察组最佳矫正视力较术前平均改善0.38 logMAR(P<0.05),对照组无显著改善(P>0.05)。
  • 两组术后抗青光眼药物数量均较术前减少,组间差异无统计学意义(P>0.05)。
  • 观察组前房积血发生率5.7%(2/35),对照组11.1%(4/36),组间差异无统计学意义(P>0.05);观察组眼压反跳发生率20.0%(7/35),显著低于对照组41.7%(15/36)(P<0.05)。
  • 术后6个月总成功率观察组88.6%、对照组80.6%,组间差异无统计学意义(P>0.05)。

关键数值与推荐

  • 术后6个月观察组眼压(15.28±2.80)mmHg,对照组15.00(13.50,18.00)mmHg。
  • 观察组最佳矫正视力平均改善0.38 logMAR(P<0.05)。
  • 观察组眼压反跳发生率20.0%(7/35),对照组41.7%(15/36)(P<0.05)。
  • 观察组总成功率88.6%,对照组80.6%(P>0.05)。

临床怎么用

  • 对POAG合并白内障患者,3T联合超声乳化及IOL植入可在降低眼压的同时显著改善视力并减少抗青光眼药物使用。
  • 联合手术组眼压反跳发生率更低,围手术期需关注前房积血等并发症。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To compare clinical outcomes of combined trabeculotome tunnelling trabeculoplasty (3T) and phacoemulsification vs. 3T alone for primary open-angle glaucoma (POAG) with cataract. Methods: Retrospective cohort study. Patients with POAG and cataract who underwent 3T combined with phacoemulsification and intraocular lens implantation or 3T alone at Chengdu Integrated Traditional Chinese and Western Medicine Hospital between January 2023 and December 2024 were enrolled. They were divided into two groups according to surgical modality: the observation group with eyes receiving 3T combined with phacoemulsification and intraocular lens implantation and the control group with those receiving 3T alone. The intraocular pressure (IOP), best-corrected visual acuity [converted to logarithm of the minimum angle of resolution(logMAR)], number of antiglaucoma medications, and complications were recorded on postoperative day 1, week 1, month 1, month 3, and month 6, and the success rate at 6 months was evaluated. Results: There were 59 patients (71 eyes), with a mean age of (62.81±7.80) years, including 38 males and 21 females. The observation group comprised 35 eyes and the control group 36 eyes. The preoperative IOP was (23.76±5.01) mmHg (1 mmHg=0.133 kPa) in the observation group and (24.56±6.08) mmHg in the control group; at 6 months postoperatively, the IOP decreased to (15.28±2.80) mmHg and 15.00 (13.50, 18.00) mmHg, respectively. Both groups showed a significant IOP reduction from baseline (P<0.05), but the difference between groups was not statistically significant (P>0.05). At 6 months, the best-corrected visual acuity in the observation group improved significantly from baseline, with a mean improvement of 0.38 logMAR (P<0.05), whereas no significant improvement was observed in the control group (P>0.05). The number of antiglaucoma medications decreased postoperatively in both groups, with no statistically significant difference between groups (P>0.05). Regarding complications, the incidence of hyphema was 5.7% (2/35) in the observation group and 11.1% (4/36) in the control group, with no statistically significant difference (P>0.05). The incidence of IOP rebound was 20.0% (7/35) in the observation group, which was significantly lower than that in the control group (41.7%, 15/36) (P<0.05). At 6 months postoperatively, the overall success rate was 88.6% in the observation group and 80.6% in the control group, with no statistically significant difference (P>0.05). Conclusions: The 6-month follow-up results of this study indicate that 3T combined with cataract extraction is a safe and effective treatment for POAG with cataract, significantly improving visual acuity, effectively reducing IOP, and decreasing the number of antiglaucoma medications, with a low rate of postoperative complications. 目的: 探究新型微创内路三联(3T)手术联合与不联合白内障超声乳化及人工晶状体(IOL)植入术治疗原发性开角型青光眼(POAG)合并白内障的短期临床疗效。 方法: 回顾性队列研究。纳入2023年1月至2024年12月于成都市中西医结合医院接受3T联合超声乳化白内障吸除及IOL植入术或单纯3T手术治疗的POAG合并白内障患者,根据手术方式分为两组,接受3T联合超声乳化白内障吸除及IOL植入术的术眼为观察组,接受单纯3T的术眼为对照组。记录术后1 d、1周、1个月、3个月及6个月的眼压、最佳矫正视力[转化为最小分辨角的对数(logMAR)]、抗青光眼药物数量和并发症及术后6个月的成功率。 结果: 共纳入患者59例(71只眼),年龄为(62.81±7.80)岁,其中男性38例,女性21例。观察组35只眼,对照组36只眼。观察组和对照组术前眼压分别为(23.76±5.01)和(24.56±6.08)mmHg(1 mmHg=0.133 kPa),术后6个月分别为(15.28±2.80)和15.00(13.50,18.00)mmHg,两组术后眼压均较术前显著降低(P<0.05),但组间差异无统计学意义(P>0.05)。术后6个月,观察组最佳矫正视力较术前明显提高,平均改善0.38(logMAR)(P<0.05),而对照组未观察到显著改善(P>0.05)。两组术后抗青光眼药物使用数量均较术前减少,组间差异无统计学意义(P>0.05)。并发症方面,观察组前房积血发生率为5.7%(2/35),对照组为11.1%(4/36),组间差异无统计学意义(P>0.05);观察组眼压反跳发生率为20%(7/35),显著低于对照组的41.7%(15/36),差异有统计学意义(P<0.05)。术后6个月,观察组总成功率为88.6%,对照组为80.6%,组间差异无统计学意义(P>0.05)。 结论: 本研究6个月的随访结果表明,3T联合白内障摘除手术是一种安全有效的治疗POAG合并白内障的方法,可显著提高视力、有效降低眼压和减少抗青光眼药物的数量,且术后并发症少。.

来源:Zhonghua Yan Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Qiu Q, He CZ, Wang SZ, et al. [Efficacy and safety of trabeculotome tunnelling trabeculoplasty with versus without phacoemulsification in patients with primary open-angle glaucoma and cataract]. Zhonghua Yan Ke Za Zhi. 2026. PMID: 42855778. doi:10.3760/cma.j.cn112142-20260411-00153

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。